Wire Stories

Zynga Launches FarmVille 3 in Japan

Latest Expansion to Iconic FarmVille Franchise Released on the Apple App Store and Google Play…

Tech Mahindra Selects Keysight’s Test Solutions to Certify 5G Vendors’ Equipment at its 5G O-RAN Lab in New Jersey, USA

Enabling end-to-end conformance, interoperability and performance validation of open RAN equipment SANTA ROSA, Calif. &…

Uniphore Acquires Colabo to Deliver Knowledge AI and Automation

Knowledge AI capabilities automate extraction of knowledge entities and graphs to empower real-time learning for…

Insights on the Disposable Gloves Global Market to 2031 – by Material, End-use and Region – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Disposable Gloves Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,…

UserTesting Announces New Capabilities that Provide Organizations with More Customizable and Powerful Machine Learning-Driven Insights

New Fuel Cycle integration enables organizations to capture more context from their known community members…

Blue Foundry Bancorp Schedules First Quarter 2022 Earnings Conference Call

RUTHERFORD, N.J., April 13, 2022 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”),…

Regarding the supplement of the agenda and proposed draft resolutions of the Ordinary General Meeting of Shareholders of INVL Technology

Special closed-ended type private equity investment company INVL Technology, legal entity code 300893533, the registered…

SES AI Celebrates Its 10th Anniversary

SES AI was founded on April 17th, 2012, originally as SolidEnergy Systems Over the past…

SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)

Early research suggests Pentarlandir is safe to use against COVID-19; Phase 3 trial evaluating effectiveness…

Propanc Biopharma’s Management Explains Why They Believe Cancer Patients Are Likely to Respond to PRP Treatment

Clinical Knowledge Obtained Increases Probability of Success Compared to Drug Products Entering Phase I without…